Price movement over the last 24 hours
Adobe Systems Inc vs Teladoc Health Inc — how do they compare? Adobe Systems Inc trades at $220.47 (market cap $88.06B), while Teladoc Health Inc trades at $9.09 (market cap $1.72B). The key difference: Adobe Systems Inc is far larger — about 51.2× Teladoc Health Inc's market cap, and Teladoc Health Inc is trading nearer its 52-week high, Adobe Systems Inc nearer its low. Which is the better fit depends on your goals.
| ADBE | TDOC | |
|---|---|---|
Market Cap | $88.06B | $1.72B |
Volume | 5,187,646 | — |
Sector | Technology | Health |
52-Week High | $382.24 | $9.52 |
52-Week Low | $193.41 | $4.47 |
Enterprise Value | $89.50B | $2.01B |
Signals from Pluang's Aura AI — not financial advice
Adobe Inc. (ADBE) trades at $220.92, up 1.31% with a bullish technical signal despite recent volatility. The company shows strong fundamentals with Q1 2026 EPS beating expectations at $5.96 versus $5.82, revenue growth to $23.77B in 2025, and robust profitability margins. However, negative net cash flow of -$2.18B in 2025 and AI competition concerns from recent news create mixed sentiment.
Outlook remains positive with a consensus price target of $246.75, representing 11.7% upside, supported by 49.21% analyst buy ratings. Key risks include AI disruption fears and CEO transition uncertainty, but Adobe's entrenched market position and double-digit growth provide a solid foundation for long-term investors.
Teladoc Health (TDOC) trades at $9.52, up 3.48% today, with technical indicators showing bullish momentum despite overbought RSI readings. The company reported Q1 2026 earnings that missed expectations, but revenue remains stable at $2.53 billion for 2025. Recent news highlights expansion through Walmart's platform and ongoing cost-cutting efforts, though BetterHelp segment weakness persists. Analyst consensus is mixed with 33% buy ratings but a price target below current levels at $7.83.
TDOC's recovery story faces headwinds from persistent net losses and negative cash flow, but low P/S ratio of 0.66 offers valuation appeal. Key risks include competitive pressure and execution challenges, while institutional sentiment remains cautious with no sell ratings. The stock's near-term direction hinges on Q2 earnings results and progress toward profitability.
Trailing returns across standard periods
Latest headlines on both assets
Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.
Read more on ADBE →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →